Here’s what to know about the Trump administration’s order and which information is still available to California residents.
The CDC on Friday is scrubbing a swath of HIV-related content from the agency’s website as a part of Trump’s broader effort ...
Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.
When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The Centers for Disease Control and Prevention is going dark, along with other federal agencies within the umbrella of the ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The Trump administration ordered an immediate pause on public communications from federal health agencies like the CDC, FDA, ...
During the year ending last August, according to preliminary estimates from the Centers for Disease Control and Prevention ...
Republicans, on the other hand, were twice as likely to trust Trump (84%), Kennedy (81%), and Mehmet Oz (83%) — who is Trump’s nominee to lead the Center for Medicaid and Medicare Services. Less than ...
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
President Donald Trump recently paused updates from health agencies like the CDC and FDA. Here’s what South Carolina ...